1995
DOI: 10.1016/0003-4975(95)98959-x
|View full text |Cite
|
Sign up to set email alerts
|

An alternative to cardioplegia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
4
0

Year Published

1996
1996
2013
2013

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 25 publications
(4 citation statements)
references
References 1 publication
0
4
0
Order By: Relevance
“…Inducing CA immediately after initiation of DHCA as done in our protocol might preserve energy stores, maintain vascular reactivity and help restore cardiac output after reperfusion. The ultra-short acting beta-blocker esmolol has been used previously to induce CA in both clinical (Pirk and Kellovsky, 1995) and experimental settings (Liachenko et al, 2001). Beta-blockers were shown to improve neurologic outcome after cardiac surgery (Amory et al, 2002) and cerebral ischemia (Goyagi et al, 2006) and could confer substantial pharmacologic protection to the effects of hypothermia in our model, partially explaining the lack of neurological deficits.…”
Section: Discussionmentioning
confidence: 78%
“…Inducing CA immediately after initiation of DHCA as done in our protocol might preserve energy stores, maintain vascular reactivity and help restore cardiac output after reperfusion. The ultra-short acting beta-blocker esmolol has been used previously to induce CA in both clinical (Pirk and Kellovsky, 1995) and experimental settings (Liachenko et al, 2001). Beta-blockers were shown to improve neurologic outcome after cardiac surgery (Amory et al, 2002) and cerebral ischemia (Goyagi et al, 2006) and could confer substantial pharmacologic protection to the effects of hypothermia in our model, partially explaining the lack of neurological deficits.…”
Section: Discussionmentioning
confidence: 78%
“…Myocardial protection with high-dose b-blockade has been clinically applied for CABG surgery [18,29,30,11], mitral valve replacement [31], and surgery of complex congenital heart disease [32]. The experimental studies presented in this paper have demonstrated an alleviation of myocardial reperfusion injury using high-dose b-blockade in comparison to reperfusion with plain blood or warm blood cardioplegia.…”
Section: Discussionmentioning
confidence: 94%
“…Recently, myocardial protection with the short acting B-blocker esmolol has been introduced as an alternative to cardioplegic arrest [3][4][5]. Clinical results showed beneficial effects of intraoperative Bblockade in patients with compromised left ventricular function and in patients undergoing emergency CABG surgery [3,6].…”
Section: Discussionmentioning
confidence: 99%